This week, we’re reading about how Medicare beneficiaries feel about the cost of their price-negotiated drugs, the role of community pharmacies and patients’ identities in immunizations, and California’s state-run insulin generic option, among many other topics.
- Axios: Scoop: Trump team tells GOP to lean in on health care
- Managed Healthcare Executive: Medicare beneficiaries are paying more for price-negotiated drugs, survey finds
- Healthcare Brew: As national payers recover, not-for-profit regional plans face an uphill battle
- Federal News Network: DoD changes transitional health care eligibility for reservists following lawsuit
- Drug Topics: Patient Worry, Identity Shape Adults’ Vaccine Perception
- Pharmacy Times: Community Pharmacy's Growing Role in Immunizations and Patient Trust
- HealthDay: Newsom Promotes Affordable Insulin, But California’s Generic Label Off To A Slow Start
- Latrobe Bulletin: For Pennsylvania pharmacies, filling a prescription can mean losing money
- The Enterprise-Tocsin: Thompson talks PBM reform at Magic Mart
- The Tribune: Palo Cedro to see changes with new pharmacy, new brewery
- The Lane Report: Norton Healthcare celebrates grand opening of Norton Pharmacy
- Press-Telegram: This community pharmacy in Lakewood hopes to be a model for the ‘future of pharmacy’
- Culture Map Austin: Austin’s Peoples Pharmacy sold to new independent owner after 46 years
- KY3: Houston, Mo., pharmacy set to close, another prepares for more patients
NCPA
